Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2444616rdf:typepubmed:Citationlld:pubmed
pubmed-article:2444616lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2444616lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2444616lifeskim:mentionsumls-concept:C0032005lld:lifeskim
pubmed-article:2444616lifeskim:mentionsumls-concept:C0529334lld:lifeskim
pubmed-article:2444616lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:2444616lifeskim:mentionsumls-concept:C0475264lld:lifeskim
pubmed-article:2444616lifeskim:mentionsumls-concept:C0021044lld:lifeskim
pubmed-article:2444616pubmed:issue5lld:pubmed
pubmed-article:2444616pubmed:dateCreated1987-11-25lld:pubmed
pubmed-article:2444616pubmed:abstractTextThe distribution of transglutaminases, the Ca2+-dependent protein cross-linking enzymes, in the human pituitary gland was investigated by immunohistological methods using specific antibodies. Tissue-type transglutaminase was specifically localized in ACTH-producing cells, and the cells producing GH, PRL, TSH, FSH, and LH contained no appreciable amount of the enzyme. No detectable plasma-type transglutaminase (coagulation factor XIII) was found in pituitary tissue. In a previous study we demonstrated that ACTH-producing cells contain very little Ca2+-dependent proteinases (calpain), but a remarkable amount of their inhibitor, calpastatin. Pituitary gland cells producing hormones other than ACTH contained calpains, but no detectable calpastatin. These results collectively suggest that intracellular substrate proteins in ACTH-producing cells are protected from Ca2+-dependent degradation and are substrates for Ca2+-dependent cross-linking catalyzed by the tissue-type transglutaminase. In other pituitary gland cells, conversely, the intracellular substrate proteins are more likely to undergo Ca2+-dependent degradation than cross-linking.lld:pubmed
pubmed-article:2444616pubmed:languageenglld:pubmed
pubmed-article:2444616pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444616pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2444616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444616pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2444616pubmed:statusMEDLINElld:pubmed
pubmed-article:2444616pubmed:monthNovlld:pubmed
pubmed-article:2444616pubmed:issn0021-972Xlld:pubmed
pubmed-article:2444616pubmed:authorpubmed-author:MurachiTTlld:pubmed
pubmed-article:2444616pubmed:authorpubmed-author:MikawaHHlld:pubmed
pubmed-article:2444616pubmed:authorpubmed-author:KitaharaAAlld:pubmed
pubmed-article:2444616pubmed:authorpubmed-author:KannagiRRlld:pubmed
pubmed-article:2444616pubmed:authorpubmed-author:YamagataYYlld:pubmed
pubmed-article:2444616pubmed:authorpubmed-author:OhtsukiHHlld:pubmed
pubmed-article:2444616pubmed:issnTypePrintlld:pubmed
pubmed-article:2444616pubmed:volume65lld:pubmed
pubmed-article:2444616pubmed:ownerNLMlld:pubmed
pubmed-article:2444616pubmed:authorsCompleteYlld:pubmed
pubmed-article:2444616pubmed:pagination885-90lld:pubmed
pubmed-article:2444616pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:meshHeadingpubmed-meshheading:2444616-...lld:pubmed
pubmed-article:2444616pubmed:year1987lld:pubmed
pubmed-article:2444616pubmed:articleTitleSpecific localization of tissue-type transglutaminase in adrenocorticotropin-producing cells of the human pituitary gland as demonstrated by immunohistochemistry.lld:pubmed
pubmed-article:2444616pubmed:affiliationDepartment of Clinical Science, Kyoto University Faculty of Medicine, Japan.lld:pubmed
pubmed-article:2444616pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2444616pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed